Revenue (Tables)

12 Months Ended

Dec. 31, 2020

Revenue from Contract with Customer [Abstract]

Schedule of Disaggregation of Revenue

The following table presents the approximate percentage of our net sales by market group:

	2020		2019		2018
Biologics	31	%	25	%	21	%
Generics	20	%	20	%	21	%
Pharma	26	%	31	%	34	%
Contract-Manufactured Products	23	%	24	%	24	%
	100	%	100	%	100	%

The following table presents the approximate percentage of our net sales by product category:

	2020		2019		2018
High-Value Product Components	46	%	42	%	41	%
High-Value Product Delivery Devices	5	%	5	%	3	%
Standard Packaging	26	%	29	%	32	%
Contract-Manufactured Products	23	%	24	%	24	%
	100	%	100	%	100	%

The following table presents the approximate percentage of our net sales by geographic location:

	2020		2019		2018
Americas	48	%	48	%	48	%
Europe, Middle East, Africa	43	%	44	%	44	%
Asia Pacific	9	%	8	%	8	%
	100	%	100	%	100	%

Schedule of Change in Contract with Customer, Asset and Liability

The following table summarizes our contract assets and liabilities, excluding contract assets included in accounts receivable, net:

	($ in millions)
Contract assets, December 31, 2019	$	9.8
Contract assets, December 31, 2020	10.9
Change in contract assets - increase (decrease)	$	1.1
Deferred income, December 31, 2019	$	(34.9)
Deferred income, December 31, 2020	(57.1)
Change in deferred income - (increase) decrease	$	(22.2)